ICON PLC
ICLR
View Detailed Chart
182.450USD
-4.130-2.21%
Market hours （ET）Quotes delayed by 15 min
13.93BMarket Cap
24.44P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.21%
5 Days
-1.84%
1 Month
+12.50%
6 Months
+25.26%
Year to Date
-13.00%
1 Year
-12.35%
View Detailed Chart
TradingKey Stock Score of ICON PLC
Currency: USD Updated: 2025-12-12Key Insights
ICON PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 17/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 205.69.In the medium term, the stock price is expected to remain stable.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
ICON PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
18
analysts
Buy
Current Rating
205.688
Target Price
+12.95%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
ICON PLC Highlights
StrengthsRisks
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 8.28B.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 8.28B.
Fairly Valued
The company’s latest PE is 25.00, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 79.42M shares, decreasing 11.52% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 571.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.06.
ICON PLC News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
ICON PLC Info
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Ticker SymbolICLR
CompanyICON PLC
CEOBalfe (Barry Edward)
Websitehttps://www.iconplc.com/
FAQs
What is the current price of ICON PLC (ICLR)?
The current price of ICON PLC (ICLR) is 182.450.
What is the symbol of ICON PLC?
The ticker symbol of ICON PLC is ICLR.
What is the 52-week high of ICON PLC?
The 52-week high of ICON PLC is 228.285.
What is the 52-week low of ICON PLC?
The 52-week low of ICON PLC is 125.100.
What is the market capitalization of ICON PLC?
The market capitalization of ICON PLC is 13.93B.
What is the net income of ICON PLC?
The net income of ICON PLC is 791.47M.
Is ICON PLC (ICLR) currently rated as Buy, Hold, or Sell?
According to analysts, ICON PLC (ICLR) has an overall rating of Buy, with a price target of 205.688.
What is the Earnings Per Share (EPS TTM) of ICON PLC (ICLR)?
The Earnings Per Share (EPS TTM) of ICON PLC (ICLR) is 7.464.
Related Instruments
+3.20%
+1.24%
+1.63%
+1.37%
+1.37%
-0.99%
+1.55%
+0.27%
+2.38%
+0.21%
-2.69%
-0.11%
+3.51%
+0.78%
+0.71%
+2.89%
+1.73%
0.00%
+1.48%
-0.06%Popular Symbols
